Toy Medical

Kumamoto, Japan · Founded 2013 · Privately Held (backing)

Producer of health-focused products designed for dietary and wellness purposes. Toy Medical is based in Kumamoto, Japan and was founded in 2013. Its last reported valuation was $16.3 million in Nov 2025. It has raised $5.1 million.

Last reported valuation
$16.3M
Oct 2026
Priced at
—
Total raised
$5.1M
Last round
—

Toy Medical key facts

as of Oct 2026
  • Producer of health-focused products designed for dietary and wellness purposes.
  • Toy Medical is valued at approximately $16.3M as of Oct 2026 (last reported valuation).
  • It has raised $5.1M; the latest was Later Stage VC ($2.0M) in Nov 2025.
  • Notable investors include Japan External Trade Organization, Leave a Nest Capital, SocialX Acceleration, Glocalink, Higin Capital — 9 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$16.3M

Toy Medical's last reported valuation, Nov 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Toy Medical with a free account
  • ·Watch Toy Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Toy Medical funding rounds

No rounds on record

No funding rounds for Toy Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Toy Medical valuation

Toy Medical's last reported valuation was $16.3 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.

Toy Medical investors

9 investors are on record for Toy Medical, including Japan External Trade Organization, Leave a Nest Capital, SocialX Acceleration and Glocalink.

About Toy Medical

Producer of health-focused products designed for dietary and wellness purposes. The company's platform incorporates proprietary salt-offset technology using seaweed-derived alginates, a potassium-free formula, and applications across supplements, seasonings, and snacks, enabling healthcare and wellness markets to manage sodium intake effectively without compromising taste, improve nutritional balance, and support long-term cardiovascular health through natural, science-backed innovations.

Sector
Consumer Products and Services (B2C)
HQ
Kumamoto, Japan
Founded
2013
Employees
14
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.